Michael F. Brigham - 31 Jan 2022 Form 4 Insider Report for IMMUCELL CORP /DE/ (ICCC)

Role
President & CEO, Director
Signature
/s/Michael F Brigham
Issuer symbol
ICCC
Transactions as of
31 Jan 2022
Net transactions value
+$8,150
Form type
4
Filing time
09 Feb 2022, 15:58:28 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICCC Incentive Stock Options (Right to buy) Award $8,150 +1,000 $8.15 1,000 31 Jan 2022 Common Stock 1,000 $8.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option grant is made subject to the reservation of more shares for the Company's 2017 Stock Option Plan by vote of stockholders at the 2022 Annual Meeting of the Company.